GigaGen
  • Our Company
    • Team
    • News
  • Our Science
    • Surge and Magnify Technologies
    • Publications, Scientific Posters & Presentations
  • Pipeline
    • Oncology
    • Recombinant Polyclonals
  • Careers
  • Contact
  • Menu Menu

GigaGen Wins Grant for Immune Repertoire Sequencing Technology

Uncategorized

SAN FRANCISCO, CA – GigaGen has won a Phase II Small Business Innovation Research (SBIR) grant for $950K from the National Cancer Institute (NCI). The funds will be used to develop and commercialize molecular kits for immune repertoire sequencing.

08/08/2014
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
©Copyright 2023 GigaGen. All Rights Reserved. | Privacy Policy | Terms | Disclaimer
  • Twitter
  • LinkedIn
Scroll to top